您的购物车当前为空
别名 盐酸雷尼替丁, AH19065
Ranitidine Hydrochloride (AH19065) 是一种具有口服活性的组胺 H2 受体选择性拮抗剂,IC50为 3.3 μM。它还是一种CYP2C19和CYP2C9的弱抑制剂,可抑制胃液分泌。

Ranitidine Hydrochloride (AH19065) 是一种具有口服活性的组胺 H2 受体选择性拮抗剂,IC50为 3.3 μM。它还是一种CYP2C19和CYP2C9的弱抑制剂,可抑制胃液分泌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 186 | In Stock | |
| 50 mg | ¥ 272 | In Stock | |
| 100 mg | ¥ 354 | In Stock | |
| 200 mg | ¥ 496 | In Stock |
Ranitidine Hydrochloride 相关产品
| 产品描述 | Ranitidine Hydrochloride (AH19065) is a member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked. |
| 靶点活性 | H2 receptor:3.3 ± 1.4 μM |
| 体外活性 | Ranitidine Hydrochloride 在大鼠体内导致肝损伤,现象是Ranitidine Hydrochloride 给药后6小时内血清谷丙转氨酶、谷草转氨酶和γ-谷氨酰转移酶活性的增加。[1] Ranitidine Hydrochloride 抑制了肝缺血/再灌注在大鼠体内引发的肝组织肿瘤坏死因子α、细胞因子诱导的中性粒细胞趋化因子的增加和中性粒细胞在肝脏的积累。[2] Ranitidine Hydrochloride 联合治疗在肝损伤发生前增强了内毒素诱导的凝血,而抗凝剂抑制了内毒素/Ranitidine Hydrochloride 处理的大鼠肝损伤。Ranitidine Hydrochloride /内毒素处理的大鼠在肝窦内形成了纤维蛋白凝块且与预防纤维蛋白沉积与降低肝细胞损伤相关。Ranitidine Hydrochloride 联合治疗增强了内毒素在大鼠肝细胞损伤发生前的肿瘤坏死因子的数量。[4] 在提高十字迷宫测试中,Ranitidine Hydrochloride 显现出抗焦虑效果,这表现为大鼠在开放臂区域的停留时间增加,开放臂的探查行为增多以及末梢探险次数的增加。[5] |
| 体内活性 | Ranitidine Hydrochloride 在大鼠体内导致肝损伤,现象是Ranitidine Hydrochloride 给药后6小时内血清谷丙转氨酶、谷草转氨酶和γ-谷氨酰转移酶活性的增加。[1] Ranitidine Hydrochloride 抑制了肝缺血/再灌注在大鼠体内引发的肝组织肿瘤坏死因子α、细胞因子诱导的中性粒细胞趋化因子的增加和中性粒细胞在肝脏的积累。[2] Ranitidine Hydrochloride 联合治疗在肝损伤发生前增强了内毒素诱导的凝血,而抗凝剂抑制了内毒素/Ranitidine Hydrochloride 处理的大鼠肝损伤。Ranitidine Hydrochloride /内毒素处理的大鼠在肝窦内形成了纤维蛋白凝块且与预防纤维蛋白沉积与降低肝细胞损伤相关。Ranitidine Hydrochloride 联合治疗增强了内毒素在大鼠肝细胞损伤发生前的肿瘤坏死因子的数量。[4] 在提高十字迷宫测试中,Ranitidine Hydrochloride 显现出抗焦虑效果,这表现为大鼠在开放臂区域的停留时间增加,开放臂的探查行为增多以及末梢探险次数的增加。[5] |
| 别名 | 盐酸雷尼替丁, AH19065 |
| 分子量 | 350.86 |
| 分子式 | C13H23ClN4O3S |
| CAS No. | 66357-59-3 |
| Smiles | Cl.CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 142.51 mM, Sonication is recommended. DMSO: 60 mg/mL (171.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.7 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容